Clinical Research Activities:

Vaginal fluid collection study for endometrial cancer screening test. C. Wilson serves as Secondary Research Study Coordinator. (Nov 2024 to Present)

A phase IV, longitudinal, observational study examining real-world outcomes of non-hormonal pharmacotherapies among individuals treated for bothersome vasomotor symptoms. Observational, Phase 4 Study. C. Wilson serves as Secondary Research Study Coordinator. (Jul 2024 to Present).

The efficacy and safety of a CCT-102 regimen or expectant management in the treatment of first trimester pregnancy loss. Interventional, Phase 3 Study. C. Wilson serves as Secondary Research Study Coordinator. (Jul 2024 to Present)

A phase 3B, single-arm, open-label study to evaluate bone mineral density with long-term use of relugolix combination tablet in premenopausal women with heavy menstrual bleeding associated with uterine fibroids or moderate to severe pain associated with endometriosis. Interventional, Phase 3 Study. C. Wilson serves as Secondary Research Study Coordinator. (Jul 2024 to Present)

Collection and banking of blood samples for the study of female gynecological diseases. C. Wilson serves as Secondary Research Study Coordinator. (Jul 2024 to Present)